Your browser doesn't support javascript.
loading
GWAS of bone size yields twelve loci that also affect height, BMD, osteoarthritis or fractures.
Styrkarsdottir, Unnur; Stefansson, Olafur A; Gunnarsdottir, Kristbjorg; Thorleifsson, Gudmar; Lund, Sigrun H; Stefansdottir, Lilja; Juliusson, Kristinn; Agustsdottir, Arna B; Zink, Florian; Halldorsson, Gisli H; Ivarsdottir, Erna V; Benonisdottir, Stefania; Jonsson, Hakon; Gylfason, Arnaldur; Norland, Kristjan; Trajanoska, Katerina; Boer, Cindy G; Southam, Lorraine; Leung, Jason C S; Tang, Nelson L S; Kwok, Timothy C Y; Lee, Jenny S W; Ho, Suzanne C; Byrjalsen, Inger; Center, Jacqueline R; Lee, Seung Hun; Koh, Jung-Min; Lohmander, L Stefan; Ho-Pham, Lan T; Nguyen, Tuan V; Eisman, John A; Woo, Jean; Leung, Ping-C; Loughlin, John; Zeggini, Eleftheria; Christiansen, Claus; Rivadeneira, Fernando; van Meurs, Joyce; Uitterlinden, Andre G; Mogensen, Brynjolfur; Jonsson, Helgi; Ingvarsson, Thorvaldur; Sigurdsson, Gunnar; Benediktsson, Rafn; Sulem, Patrick; Jonsdottir, Ingileif; Masson, Gisli; Holm, Hilma; Norddahl, Gudmundur L; Thorsteinsdottir, Unnur.
Affiliation
  • Styrkarsdottir U; deCODE genetics/Amgen Inc., Reykjavik, 101, Iceland. unnur.styrkarsdottir@decode.is.
  • Stefansson OA; deCODE genetics/Amgen Inc., Reykjavik, 101, Iceland.
  • Gunnarsdottir K; deCODE genetics/Amgen Inc., Reykjavik, 101, Iceland.
  • Thorleifsson G; deCODE genetics/Amgen Inc., Reykjavik, 101, Iceland.
  • Lund SH; deCODE genetics/Amgen Inc., Reykjavik, 101, Iceland.
  • Stefansdottir L; Faculty of Medicine, University of Iceland, Reykjavik, 101, Iceland.
  • Juliusson K; deCODE genetics/Amgen Inc., Reykjavik, 101, Iceland.
  • Agustsdottir AB; deCODE genetics/Amgen Inc., Reykjavik, 101, Iceland.
  • Zink F; deCODE genetics/Amgen Inc., Reykjavik, 101, Iceland.
  • Halldorsson GH; deCODE genetics/Amgen Inc., Reykjavik, 101, Iceland.
  • Ivarsdottir EV; deCODE genetics/Amgen Inc., Reykjavik, 101, Iceland.
  • Benonisdottir S; deCODE genetics/Amgen Inc., Reykjavik, 101, Iceland.
  • Jonsson H; deCODE genetics/Amgen Inc., Reykjavik, 101, Iceland.
  • Gylfason A; deCODE genetics/Amgen Inc., Reykjavik, 101, Iceland.
  • Norland K; deCODE genetics/Amgen Inc., Reykjavik, 101, Iceland.
  • Trajanoska K; deCODE genetics/Amgen Inc., Reykjavik, 101, Iceland.
  • Boer CG; Department of Epidemiology, ErasmusMC, 3015 GD, Rotterdam, The Netherlands.
  • Southam L; Department of Internal Medicine, ErasmusMC, 3015 GD, Rotterdam, the Netherlands.
  • Leung JCS; Department of Internal Medicine, ErasmusMC, 3015 GD, Rotterdam, the Netherlands.
  • Tang NLS; Wellcome Trust Sanger Institute, Hinxton, CB10 1SA, UK.
  • Kwok TCY; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
  • Lee JSW; Jockey Club Centre for Osteoporosis Care and Control, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
  • Ho SC; Faculty of Medicine, Department of Chemical Pathology and Laboratory for Genetics of Disease Susceptibility, Li Ka Shing Institute of Health Sciences,, The Chinese University of Hong Kong, Hong Kong, China.
  • Byrjalsen I; CUHK Shenzhen Research Institute, Shenzhen, 518000, China.
  • Center JR; Jockey Club Centre for Osteoporosis Care and Control, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
  • Lee SH; Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, China.
  • Koh JM; Faculty of Medicine, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
  • Lohmander LS; Department of Medicine, Alice Ho Miu Ling Nethersole Hospital and Tai Po Hospital, Hong Kong, China.
  • Ho-Pham LT; JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
  • Nguyen TV; Nordic Bioscience A/S, 2730, Herlev, Denmark.
  • Eisman JA; Bone Biology Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
  • Woo J; School of Medicine Sydney, University of Notre Dame Australia, Sydney, NSW, 2010, Australia.
  • Leung PC; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, 2010, Australia.
  • Loughlin J; Division of Endocrinology and Metabolism, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, Korea.
  • Zeggini E; Division of Endocrinology and Metabolism, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, Korea.
  • Christiansen C; Orthopaedics, Department of Clinical Sciences Lund, Lund University, SE-22 100, Lund, Sweden.
  • Rivadeneira F; Bone and Muscle Research Lab, Ton Duc Thang University, Ho Chi Minh City, 700000, Vietnam.
  • van Meurs J; Bone Biology Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
  • Uitterlinden AG; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, 2010, Australia.
  • Mogensen B; School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW, 2007, Australia.
  • Jonsson H; Bone Biology Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
  • Ingvarsson T; School of Medicine Sydney, University of Notre Dame Australia, Sydney, NSW, 2010, Australia.
  • Sigurdsson G; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, 2010, Australia.
  • Benediktsson R; Clinical Translation and Advanced Education, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
  • Sulem P; Faculty of Medicine, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
  • Jonsdottir I; Jockey Club Centre for Osteoporosis Care and Control, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
  • Masson G; Institute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China.
  • Holm H; Institute of Genetic Medicine, Newcastle University, Newcastle-upon-Tyne, NE1 7RU, UK.
  • Norddahl GL; Wellcome Trust Sanger Institute, Hinxton, CB10 1SA, UK.
  • Thorsteinsdottir U; Institute of Translational Genomics, Helmholtz Zentrum München, 85764, München, Germany.
Nat Commun ; 10(1): 2054, 2019 05 03.
Article de En | MEDLINE | ID: mdl-31053729
ABSTRACT
Bone area is one measure of bone size that is easily derived from dual-energy X-ray absorptiometry (DXA) scans. In a GWA study of DXA bone area of the hip and lumbar spine (N ≥ 28,954), we find thirteen independent association signals at twelve loci that replicate in samples of European and East Asian descent (N = 13,608 - 21,277). Eight DXA area loci associate with osteoarthritis, including rs143384 in GDF5 and a missense variant in COL11A1 (rs3753841). The strongest DXA area association is with rs11614913[T] in the microRNA MIR196A2 gene that associates with lumbar spine area (P = 2.3 × 10-42, ß = -0.090) and confers risk of hip fracture (P = 1.0 × 10-8, OR = 1.11). We demonstrate that the risk allele is less efficient in repressing miR-196a-5p target genes. We also show that the DXA area measure contributes to the risk of hip fracture independent of bone density.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Arthrose / Densité osseuse / MicroARN / Fractures de la hanche Type d'étude: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2019 Type de document: Article Pays d'affiliation: Islande

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Arthrose / Densité osseuse / MicroARN / Fractures de la hanche Type d'étude: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2019 Type de document: Article Pays d'affiliation: Islande
...